No envíes un currículum genérico: crea un currículum y una carta de presentación adaptados a este puesto concreto.
Johnson & Johnson is seeking a Medical Science Liaison in Hematology to build peer‑to‑peer scientific relationships with hematologists, KOLs, and academic centers in the assigned region. The MSL will provide balanced scientific exchange, support evidence generation, and help execute the medical affairs strategy.
The role requires deep disease knowledge, strong communication and presentation skills, and the ability to travel up to 40% while maintaining Credo values and scientific integrity.
Medical Affairs Group
Medical Science Liaison
Scientific/Technology
Mexico City, Mexico
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.Learn more at jnj.com .
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
The Medical Science Liaison (MSL) Hematology serves as a field-based scientific expert responsible for establishing and maintaining peer-to-peer relationships with hematologists, key opinion leaders (KOLs), academic institutions, and other healthcare stakeholders. The MSL provides balanced scientific exchange, generates actionable medical insights, supports evidence generation activities, and contributes to the execution of the medical affairs strategy in hematologic malignancies.